The Joint Corp. Stock News

Molina (MOH) delivered earnings and revenue surprises of 2.13% and 3.97%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Merck (MRK) delivered earnings and revenue surprises of 23.29% and 7.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

The Joint Corp. (JYNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Joint Corp. (JYNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Although several discounts are in play due to recent market volatility, these small-cap stocks may deliver a much bigger bang for your buck. The post 7 Small-Cap Stocks to Buy for Big Results in 2022

These superb businesses have the potential to generate solid returns for a long time.

- Grows Annual System-Wide Sales 39%, Compared to 2020 -- Increases Comp Sales of 29%, Compared to 2020 - - Opens 130 New Clinics, Up from 73 in 2020 -

The market has been pessimistic about these companies lately. Use this to your advantage.

WINTON GROUP Ltd lowered its stake in The Joint Corp. (NASDAQ:JYNT) by 24.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,466 shares of the companys stock after selling 3,711 shares during the quarter. WINTON GROUP Ltds holdings in Joint were worth []

Riding the wellness craze has been an absolute boon for this business and its shareholders.

New Jersey, United States,- The "Global Chiropractic Medicine Industry, 2021 Market Research Report" provides a detailed overview of the further development of the market for Chiropractic Medicine. The Market Research Intellect is now publishing a new market analysis with the

Shares of The Joint Corp. (NASDAQ:JYNT) have received an average rating of Buy from the eight analysts that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price objective among []

Mesirow Financial Investment Management Inc. decreased its stake in The Joint Corp. (NASDAQ:JYNT) by 2.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 5,406 shares of the companys stock after selling 154 shares during the period. Joint comprises 1.6% of Mesirow Financial Investment Management Inc.s holdings, making the stock its 17th largest position. Mesirow []

Morgan Stanley boosted its holdings in shares of The Joint Corp. (NASDAQ:JYNT) by 131.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 139,167 shares of the companys stock after buying an additional 79,076 shares during the quarter. Morgan Stanley owned approximately 0.97% []